Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
A newer version of this guideline has been published: Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up (2026)
- Study type
- Clinical guideline
- Study name
- ESMO mCRC 2022
- Design
- Clinical guideline (ESMO Guidelines Committee)
- Sample size
- Not applicable (clinical guideline)
- Source
- Annals of Oncology · 2023
In plain words
This article is the clinical guideline of the European Society for Medical Oncology (ESMO) on the diagnosis, treatment and follow-up of colorectal (bowel) cancer at the metastatic stage (spread to other organs). The guideline was developed to help doctors make decisions about patient care. The right treatment should always be chosen with the treating doctor, based on each patient's situation.
Study population
The PubMed record has no abstract. According to the title, the target population of the guideline is patients with metastatic colorectal cancer. Further details are available in the full text of the paper.
Endpoints
Not applicable (clinical guideline). The PubMed record has no abstract.
Safety and side effects
The PubMed record gives no information on adverse effects. Details are available in the full text of the paper.
Clinical significance and place in guidelines
The PubMed record has no abstract or text of the recommendations; therefore specific recommendations or their levels of evidence cannot be extracted from this record. This document is the official ESMO Guidelines Committee guideline for metastatic colorectal cancer. The exact recommendations should be extracted from the full text of the paper and reviewed by an oncologist.
Limitations
The PubMed record does not include an abstract, the text of the recommendations or levels of evidence. The content of this card is based only on the bibliographic information of the record, and the full text of the guideline needs to be reviewed to complete it.
This summary was prepared by the editorial team from the published paper; the original paper is the final reference. Read the original abstract on PubMed.